EWEdwards Lifesciences Corp
Orthopedic, Prosthetic & Surgical Appliances & Supplies
- Revenue
- $6.1B
- 12% YoY
- Operating margin
- 20.8%
- 18% YoY
- EBITDA
- $1.4B
- 7.4% YoY
- Market cap
- —
- Employees
- —
- Net debt / EBITDA
- -1.6×
- −$2.3B net debt
- AI in 10-K
- —
Red flags 0 of 9
- TSR below peersClear—3+ of last 5 years
- High CEO pay despite TSRClear—Median CEO pay ≥ $15M and TSR flag
- Active 13DClear0 filingsActive-intent 13D in 18 months
- Net insider sellingClear$0 netNet sales over $10M in 12 months
- Earnings not backed by cashClear149% of net incomeCash flow under 80% of net income
- Dilutive SBCClear3% of revenueOver 10% of revenue
- Payouts exceed cash flowClear56% of cash flowBuybacks + dividends over cash flow
- Goodwill-heavyClear14% of assetsOver 40% of assets
- Shareholder dissentClear—Any vote under 80% support
Financials
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | YoY |
|---|---|---|---|---|---|---|
| Revenue | $5.2B | $4.5B | $5.0B | $5.4B | $6.1B | 12% |
| Operating income | $1.7B | $1.5B | $1.3B | $1.4B | $1.3B | 8.3% |
| Net income | $1.5B | $1.5B | $1.4B | $4.2B | $1.1B | 74% |
| Operating cash flow | $1.7B | $1.2B | $896M | $542M | $1.6B | 194% |
| Capex | $326M | $245M | $253M | $252M | $260M | 3.1% |
| Stock-based comp | $109M | $127M | $139M | $162M | $158M | 2.6% |
| Buybacks | $513M | $1.7B | $880M | $1.2B | $893M | 23% |
Deal filings
None.
13D filers
None on file.
Insider trading
- Open-market buys, 12 mo
- $0 · 0
- Open-market sells, 12 mo
- $1M · 4
- Net
- −$1M
Pay vs performance
No pay-versus-performance disclosure yet.